Interleukin 17 (IL-17)-producing helper T cells (T H
17 cells) have been described as a functionally new CD4 helper T cell subset that is important in the pathogenesis of many organ-specific autoimmune diseases in animal models, and higher IL-17 expression has been associated with human autoimmune diseases, including multiple sclerosis 1,2 , rheumatoid arthritis 3 and psoriasis 4 . Furthermore, IL-17-producing T cells with specificity for myelin antigen are more efficient than are T helper type 1 (T H 1) cells in transferring autoimmunity in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis 5 . There is great interest in understanding the regulation of T H -17 differentiation. IL-6 and transforming growth factor-b (TGF-b) are sufficient for the differentiation of naive CD4 + T cells into IL-17-producing T cells in vitro, and these cytokines are required for T H -17 differentiation in vivo as well 6, 7 . Another crucial factor for the development of pathogenic T H -17 cells is IL-23, as IL-23p19-deficient mice have a defect in T H -17 development and are resistant to EAE 5, 8 . Initial studies of T H -17 differentiation using total CD4 + T cells, including effector-memory T cell populations, were interpreted to suggest that IL-23 is a differentiation factor for T H -17 cells 5, 8, 9 . However, it is now appreciated that naive CD4 + T cells do not express the IL-23 receptor (IL-23R) and that IL-23 alone is not able to drive the T H -17 differentiation of naive T cells 7 . Instead, IL-23 acts on previously differentiated T H -17 cells to expand their populations, stabilize them and maintain their T H -17 phenotype 5, 6, 10 .
In addition to IL-6, IL-21 (A001258), a member of the IL-2 cytokine family, is involved in T H -17 differentiation; in combination with TGF-b, IL-21 induces the expression of IL-17, the transcription factor RORgt and IL-23R in naive CD4 + T cells. In vivo, IL-21 can generate T H -17 cells even in IL-6-deficient mice, and both IL-21-deficient and IL-21R-deficient mice are defective in generating T H -17 cells. Furthermore, once they have developed, T H -17 cells secrete large amounts of IL-21, which then acts to amplify the T H -17 response in an autocrine way 11, 12 .
However, T H -17 cells are not the only T cells that produce IL-21. Another type of CD4 + T helper cell, follicular helper T cells (T FH cells), also produces large amounts of this cytokine 13, 14 . The T cell-dependent B cell response occurs in particular structures in the secondary lymphoid organs, the germinal centers. T FH cells provide cognate help to B cells in the germinal center dynamic microenvironment that results in somatic hypermutation, class-switch recombination and the selection of high-affinity B cells 15, 16 . T FH cells are distinct from conventional helper T cells (such as T H 1 and T H 2 cells) and were first characterized on the basis of expression of the chemokine receptor CXCR5. After being activated by antigen, T FH cells begin to express CXCR5 while downregulating expression of the chemokine receptor CCR7, which enables the cells to respond to the follicleassociated chemokine CXCL13. CXCR5 + CD4 + T FH cells then migrate to follicles, where they support germinal center formation and B cell responses. T FH cells express other activation markers as well, including CD69, CD95, CD40L and inducible T cell costimulator (ICOS; A001155), which has been linked to the development of T FH cells 17, 18 .
As for the function of ICOS in the development of helper T cells other than T FH cells, studies have suggested that ICOS is also essential for the development of T H -17 cells 9 . ICOS is a member of the CD28 family of coreceptor molecules that is induced on T cells after activation 19 ; B cells, macrophages and dendritic cells have constitutively low expression of its ligand, ICOS-L (also called B7h, GL50, LICOS and B7RP-1), which is further upregulated after activation of these cells. Although mice deficient in ICOS and ICOS-L have defects in CD4 + helper T cell responses, it is unclear where ICOS acts in T H -17 developmental pathway and if ICOS affects the differentiation, 'amplification' or maintenance and/or stabilization of T H -17 cells.
As mentioned above, ICOS is also involved in controlling the development and function of T FH cells. Both ICOS-deficient and ICOS-L-deficient mice have defects in humoral immunity characterized by less immunoglobulin E and G1 in the serum and defects in antibody class switching and germinal center formation 20, 21 . In addition, patients who have a total defect in ICOS expression show a profound defect in B cell maturation and immunoglobulin isotype switching 22, 23 ; such ICOS deficiency is associated with impaired development of CXCR5 + T FH cells and humoral immune responses both in humans and mice 24, 25 . Both T FH and T H -17 cells produce IL-21, a cytokine required for the 'amplification' of T H -17 cells. Here we examine the relationship between T H -17 and T FH cells with the aim of shedding new light on the function of ICOS in these T helper cells. Although initial work suggested that ICOS is critical for T H -17 differentiation 9 , that study preceded the present understanding of the steps involved in T H -17 differentiation 26 .
Here we demonstrate that the differentiation of T H -17 cells from naive CD4 + T cells did not require ICOS; instead, ICOS was critical for T H -17 maintenance and function by regulating the production of IL-21, which contributes to the expression and the maintenance of IL-23R. Furthermore, we show that both T H -17 cells and T FH cells had high relative expression of the transcription factor c-Maf (A003947) as compared to the other T H -cell subset and that loss of c-Maf resulted in a defect in IL-21 production and population expansion of T H -17 and T FH cells, phenotypes similar to those produced by loss of ICOS. Thus, c-Maf induced by ICOS regulates IL-21 production that in turn regulates the population expansion of T H -17 cells and T FH cells.
RESULTS

ICOS is not crucial for T H -17 differentiation
ICOS is important for the effector function of T cells, especially for the development of T H 2 responses 27, 28 , and it has been suggested that ICOS is also involved in the differentiation of T H -17 cells 9 . To reassess the function of ICOS in the primary differentiation of T H -17 cells, we sorted naive CD4 + CD62L hi T cells from wild-type or ICOS-deficient (Icos -/-) C57BL/6 mice and differentiated them in vitro in the presence of IL-6 and TGF-b. After 5 d of culture in those conditions, there was a similar frequency of IL-17-secreting cells in Icos -/-and wild-type CD4 + T cell cultures (Fig. 1a) and similar amounts of IL-17 production, as detected by enzyme-linked immunosorbent assay (ELISA; Fig. 1b) . These results indicate that ICOS is not required for primary T H -17 differentiation in vitro.
As T H -17 cells have been shown to be the main pathogenic population in the induction of EAE and other autoimmune diseases 5, 29, 30 , we next studied the function of ICOS in driving T H -17 differentiation during the course of EAE. We analyzed the priming of T cells after immunizing wild-type and Icos -/-mice with a peptide of myelin oligodendrocyte glycoprotein (amino acids 35-55; MOG(35-55)) emulsified in complete Freund's adjuvant (CFA). We collected draining lymph nodes, spleens and central nervous systems from the mice during the priming phase at day 10 after immunization before they showed any clinical signs of disease (Fig. 2) . Intracellular cytokine staining showed an equivalent frequency of CD4 + splenocytes that produced IL-17 or interferon-g (IFN-g) in wild-type and Icos -/-mice. Notably, CD4 + T cells in the draining lymph nodes of Icos -/-mice had a substantial increase of the percentage of cells producing IL-17 than did those of wild-type mice (5% versus 2.5%) but the percentage of IFN-g-producing CD4 + T cells was not significantly different between the two strains. Furthermore, when we analyzed the CD4 + T cells infiltrating the central nervous system, we noted that there were more CD4 + T cells that produced IL-17 in Icos -/-mice than in wild-type mice (56% versus 36%; Fig. 2a ). However, this higher frequency in T H -17 cells did not persist throughout the course of disease. After the first sign of disease or at the peak of the disease, the percentage of IL-17 cells was about the same in wild-type and Icos -/-mice (data not shown).
We also compared the antigen-specific responses of wild-type and Icos -/-CD4 + T cells to MOG . For this, we immunized wildtype and Icos -/-mice with MOG(35-55) emulsified in CFA, collected the draining lymph nodes 5 d after immunization and cultured the lymph node cells in the presence of the immunizing peptide. In these conditions, lymph node cells from the Icos -/-mice proliferated more in vitro in response to the immunizing antigen than did cells from wild-type mice (Fig. 2b) , and they produced more IL-17 and less IL-10, but the same amount of IFN-g, as detected by cytokine ELISA or intracellular cytokine staining (Fig. 2c,d) . That difference in the priming of T cells was associated with a slightly but significantly greater severity of EAE in Icos -/-mice (Fig. 2e ). There were no differences in the incidence of disease, but the mean maximum disease score was higher for Icos -/-mice (3.42 ± 0.92) than for wild-type mice (2.5 ± 0.53; Table 1 ). These data collectively suggest that costimulation of CD4 + T cells by ICOS is not required for the differentiation or priming of T H -17 cells or for the development of acute EAE. These results are consistent with published results showing that Icos -/-mice have a more severe form of EAE 20 associated with less production of IL-10 and more production of IL-17 during the acute phase of the disease.
Because T H -17 cells have been shown to be constitutively present in the intestinal lamina propria 27 , we analyzed the presence of IL-17-producing T cells in the gut of Icos -/-mice. We found considerable variability in the frequency of IL-17-producing cells in the gut of Icos -/-and wild-type mice and no significant differences in the frequency of T H -17 cells in the gut of these mice. Thus, ICOS may not be the critical regulator of T H -17 cells in the gut ( Supplementary  Fig. 1a online) . (Fig. 3a) . Furthermore, in vitro population expansion of T cells from naive mice by stimulation with antibody to CD3 (anti-CD3) and IL-23 resulted in a fourfold higher proportion of IL-17-producing cells among T FH cells than in the CD4 + CXCR5 -(non-T FH cell) fraction (8% versus 2%), whereas these populations had similar percentages of IFN-g-producing cells (Fig. 3b) . The data reported above have shown that T FH cells in wild-type mice were enriched for IL-17 production. However, one interpretation of the data is that the higher IL-17 expression in T FH cells than in CD4 + CXCR5 -non-T FH cells could have been simply due to the extent of activation of the cells. Indeed, T FH cells are uniformly activated CD4 + cells, whereas CD4 + CXCR5 -T cells comprise a mixture of activated and nonactivated T cells. To resolve that issue, we sorted three different T cell populations from draining lymph nodes and spleens of immunized mice (CD4 + ICOS hi CXCR5 + T FH cells, activated CD4 + ICOS hi CXCR5 -and nonactivated CD4 + ICOS lo CXCR5 -T cells) and then compared the expression of IL-21, IL-17 and IL-23R in these cell fractions. As anticipated, the expression of IL-17, IL-21 and IL-23R in nonactivated CD4 + T cells (CD4 + ICOS lo CXCR5 -) was low, but we detected higher expression of IL-21, IL-17 and IL-23R in activated CD4 + ICOS hi CXCR5 + T FH cells than in activated ICOS hi effector T cells (Fig. 3c) . We then expanded the three populations of CD4 + T cells in vitro by stimulating them for 4 d with IL-12 or IL-23 and then measured their cytokine production. In the presence of IL-23, CD4 + ICOS hi CXCR5 + T FH cells produced about twofold more IL-17 than did activated CD4 + ICOS hi CXCR5 -T cells, but when expanded in presence of IL-12, all three cell populations had equivalent expression of IFN-g (Fig. 3d) . These data show that the heterogeneous population of T FH cells is enriched for IL-17-producing cells that have high expression of IL-23R and that are able to produce substantial IL-17 in response to IL-23.
Development of IL-17-secreting T FH cells requires ICOS
As ICOS has been shown to be crucial for the development of T FH cells, IL-21 production and germinal center formation in both mice 24, 25 and humans 23 , we examined the effect of a lack of ICOS in the generation of IL-17-secreting T FH cells. We immunized wildtype and Icos -/-mice with MOG(35-55) emulsified in CFA and on day 6, sorted T FH cells on the basis of their expression of CD4 and CXCR5 (Fig. 4a) . As reported before 25, 32 , there were profoundly fewer CD4 + CXCR5 + cells in the draining lymph nodes and spleens of Icos -/-mice, although some CD4 + CXCR5 + cells were present (Fig. 4a) . When we compared the expression of IL-21 and IL-17 in the T FH cells of wild-type mice and the few CD4 + CXCR5 + cells in the Icos -/-mice, the latter cells showed much less production of IL-21 and IL-17, even after adjustment for cell numbers (Fig. 4b,c) . Fig. 1b) .
We also compared the capacity of T FH cells from wild-type and Icos -/-mice to respond to IL-23. We sorted CD4 + CXCR5 + T cells from immunized wild-type and Icos -/-mice and restimulated them for 4 d with antigen-presenting cells (APCs), anti-CD3 and IL-23. We then stained the CD4 + CXCR5 + T cells for intracellular expression of IL-17 and IFN-g. T FH cell from Icos -/-mice produced much less IL-17 but more IFN-g than did T FH cells from wild-type mice (Fig. 4d) . Finally, because the data indicated that ICOS was required for IL-17 production by T FH cells, we measured IL-23R expression by RT-PCR in sorted 
T FH cells from draining lymph nodes and spleens from wild-type and
Icos -/-mice to determine the importance of IL-23R for IL-17 production. Indeed, we found a much less IL-23R expression in Icos -/-T FH cells (Fig. 4e) . We also noted a similar defect in IL-23R expression in T FH (CD4 + ICOS hi CXCR5 + ) cells from ICOS-L-deficient mice ( Supplementary Fig. 1b ). These data show that ICOS is important for the generation of IL-17-producing T FH cells but not IFN-gproducing T cells and that T FH cells are compromised in Icos -/-mice.
Defective secondary responses of Icos -/-T cells
As Icos -/-cells had no defect in T H -17 differentiation in the presence of IL-6 plus TFG-b, we compared the responsiveness of Icos -/-and wildtype T cells to IL-23. We first cultured total CD4 + T cells from nonimmunized wild-type or Icos -/-mice in the presence of IL-23 to expand in vivo-differentiated T H -17 cell populations. During activation in the presence of IL-23, we noted less population expansion of IL-17-producing cells in Icos -/-mice (Fig. 5a) . As in vivodifferentiated T H -17 cells reside in the memory pool of T cells, we sorted the subset of effector-memory CD62L lo CD4 + T cells from nonimmunized wild-type and Icos -/-mice and then stimulated the cells with IL-23. In these conditions, we found that the decrease in T H -17 cells was even more profound: Icos -/-effector-memory CD4 + T cells produced 20% less IL-17 in presence of IL-23 than did wildtype effector-memory CD4 + T cells (Fig. 5a ). To further study this effect of ICOS deficiency, we differentiated naive wild-type or Icos -/-CD4 + T cells in vitro for 5 d with IL-6 and TGF-b and then further cultured the cells for another 3-4 d in the presence of IL-23. In these conditions, Icos -/-CD4 + T cells yielded B20-30% less frequency of IL-17-producing T cells than did wild-type CD4 + T cells (Fig. 5b) . Fig. 5c) . Thus, these data suggest that Icos -/-cells do not have a primary defect in T H -17 differentiation but instead have a defect in population expansion in response to IL-23. We next investigated whether IL-23 unresponsiveness was a reflection of lower expression of IL-23R or less production of IL-21 during T H -17 differentiation. At the end of the differentiation (at day 5), naive CD4 + T cells from Icos -/-mice differentiated in the presence of IL-6 and TGF-b showed 50% less IL-23R expression but only slightly lower expression of the IL-12Rb1 common chain than that of wildtype T H -17 cells (Fig. 5d) , whereas the percentage of IL-17-producing cells and the amount of IL-17 mRNA expression were equivalent in both cultures (data not shown). Those data were consistent with our observation that there was no defect in T H -17 differentiation in Icos -/-mice ( Fig. 1) and, furthermore, that differentiating T H -17 cells had lower expression of IL-23R. These data suggest that costimulation of conventional T H -17 cells through ICOS is necessary for either maximum IL-23R expression or maintenance of IL-23R expression. We also noted less production of IL-21 and IL-22 by Icos -/-T H -17 cells (Fig. 5e and Supplementary Fig. 1c ) during primary differentiation with IL-6 and TGF-b. Because IL-21 has been linked not only to T H -17 differentiation but also to IL-23R upregulation, it is possible that the lower expression of IL-23R in Icos -/-mice was secondary to less production of IL-21 by T cells. Fig. 6a) . Expression of c-Maf in T H -17 cells was over 500 times higher than that of T H 1 or T H 2 cells. Similarly, CD4 + ICOS hi CXCR5 + T FH cells had higher expression of c-Maf than did CD4 + ICOS hi CXCR5 -or CD4 + ICOS lo CXCR5 -non-T FH cells (Fig. 6a) . We then measured c-Maf expression during T H -17 differentiation of Icos -/-cells stimulated with wild-type APCs in presence of IL-6 and TFG-b. We found that Icos -/-T H -17 cells did not upregulate c-Maf expression, which confirmed the published observation that ICOS is crucial for c-Maf upregulation in T H 0 effector cells 33 . Because c-Maf regulation occurs 'downstream' of ICOS signaling, we assessed whether c-Maf-deficient cells were a 'phenocopy' of ICOS-deficient cells. For this, we differentiated naive CD4 T cells from c-Maf-deficient mice for 4 d in the presence of IL-6 plus TGF-b and then evaluated the frequency of IL-17-secreting cells. We noted a similar frequency of IL-17-secreting c-Maf-deficient and wild-type CD4 + T cells (Fig. 6b) . Therefore, like ICOS, c-Maf is not required for T H -17 differentiation. However, we speculated that like ICOS, c-Maf would be required for the maintenance of IL-17-producing cells after they had been differentiated. To test that, we restimulated the naive CD4 + T cells from c-Maf-deficient mice described above, stimulated them for 4 d with IL-6 and TGF-b and then for an additional 3 d with IL-23. Again, like ICOS-deficient T cells, c-Maf-deficient T cells yielded a 20% lower frequency of IL-17-producing T cells than did wild-type T cells (Fig. 6c) . We further confirmed the lower frequency of IL-17 + T cells in c-Maf-deficient mice by measuring IL-17 production by ELISA (Fig. 6c) . We also measured IL-23R expression during the differentiation of c-Maf-deficient cells in T H -17-polarizing conditions (IL-6 and TGF-b for 4 d). At an early time during primary differentiation (day 3), we detected the same amount of IL-23R expression in c-Maf-deficient and wild-type cells; however, after secondary expansion (IL-23 for an additional 4 d), expression of IL-23R was lower in c-Maf-deficient cells, which correlated with the lower frequency of T H 17 cells (Fig. 6d) . Finally, because ICOS-deficient mice have a defect in IL-21 production, we also analyzed IL-21 production by c-Mafdeficient cells cultured in T H -17-polarizing conditions. Again similar to ICOS deficiency, IL-21 production by c-Maf-deficient cells was lower than that of wild-type cells (Fig. 6e) . These data suggest that c-Maf is not necessary for inducing transcription of IL-23R but is more likely necessary for maintaining IL-23R expression by inducing IL-21.
ICOS regulates IL-21 production through c-Maf
Because IL-21 has been shown to be crucial for germinal center formation and T FH development, we also investigated whether c-Maf was involved in the development of T FH cells. For this, we immunized wild-type and c-Maf-deficient mice with a fusion of trinitrophenyl and ovalbumin emulsified in CFA and analyzed draining lymph nodes and spleens after 7 d. We noted many fewer CD4 + ICOS hi CXCR5 + cells in the draining lymph nodes (Fig. 6f) and spleens (data not shown) of c-Maf-deficient mice. These data collectively indicate that c-Maf participates in the development of T FH and T H -17 cells, most likely by regulating IL-21 production.
DISCUSSION
In this study we have shown that conventional T H -17 cells did not require ICOS costimulation for their differentiation or to acquire the pathogenic potential to induce EAE but instead that ICOS was necessary for the IL-23-driven population expansion of already differentiated T H 17 cells. We have further shown that the defect in the population expansion of differentiated T H -17 cells and in the It has been proposed that ICOS is required for T H -17 differentiation 9 . However, as ICOS-deficient mice are more susceptible to EAE than are wild-type mice 20 and T H -17 cells are critical for the induction of EAE, those paradoxical results raise the question of which step of T H -17 development requires ICOS. Using ICOS-deficient mice, we have reanalyzed the function of ICOS in various steps of T H -17 differentiation. In vitro, we found no defect in 'acute' T H -17 differentiation in Icos -/-mice. In contrast, in vivo, in immunized mice we found more IL-17 production and less IL-10 production during the priming phase in Icos -/-mice; this may be one reason why Icos -/-mice are more susceptible to EAE. That observation is consistent with reports showing that Icos -/-mice are more susceptible to EAE and experimental autoimmune uveoretinitis 20, 34 . Our studies have indicated that this greater susceptibility to these autoimmune disorders is not due to a primary defect in the generation of T H -17 cells after immunization but is most likely due to a loss of IL-10-producing T cells. Indeed, IL-10 secretion by T cells is stimulated by ICOS signaling 19, 35, 36 , and IL-10 is a key immunoregulatory cytokine involved in the induction of T regulatory type 1 cells, the function of Foxp3 + regulatory T cells and the suppression of autoimmunity 37, 38 .
Icos -/-mice have a defect in the development of T FH cells; here we have shown that they have a defect in IL-21 production. As IL-21 is an 'amplification' factor for T H -17 cells and T FH cells produce copious amounts of IL-21, we examined the link between T H -17 cells and T FH cells and found enhanced expression of molecules associated with T H -17 cells, including IL-17, IL-21 and IL-23R, in IL-17-producing T FH cells. IL-17 is associated with the development of autoantibody responses, and deficiency in IL-17 or blockade of IL-17 also is decreased in antibody responses 29, 39 . Another study has further shown that IL-17 is crucial for the development of autoreactive germinal centers in autoimmune BXD2 mice 40 . That study reported that IL-17-producing T cells and IL-17R + B cells localize together in germinal centers and IL-17 is involved in germinal center formation in vivo 40 . This suggests that IL-17 not only induces tissue inflammation by acting on the IL-17R expressed on the parenchymal and other tissue cells but also could function on B cells to promote the germinal center reaction. As a fraction of CXCR5-and ICOS-expressing T FH cells were IL-17-producing cells, our results suggest that the IL-17-producing cells reported before 40 are most likely T FH cells.
The crucial function of ICOS in germinal center development and the generation of T FH cells is well established; ICOS-or ICOS-Ldeficient mice develop fewer and smaller germinal centers after immunization, associated with impaired T cell-dependent B cell responses and impaired isotype class switching 20, 21, 41, 42 . Similar impairments in B cell responses have been reported subsequently in ICOS-deficient patients 25 . Furthermore, sanroque mice, which carry a disruptive mutation in the gene encoding roquin, a repressor of ICOS, develop a severe autoimmune, lupus-like disease associated with high expression of IL-21, accumulation of CXCR5 + ICOS hi T cells, more formation of germinal centers and more production of autoantibodies 43, 44 . Whether these mice also show enhanced expression of IL-17-and T H -17-associated genes in T FH cells has not been addressed, but our results suggest that part of the phenotype of sanroque mice may also be due to enhanced IL-17 production by T H -17 and T FH cells. These observations collectively suggest that the defects in the number of T FH cells and in germinal center reaction, as well as the defect in class switching, of ICOS-deficient mice and ICOS-deficient patients may be due in part to a defect in IL-21 production, which acts as an autocrine growth factor to expand T FH cell populations.
After 40 , which suggests that IL-23 may be important for the population expansion of IL-17 + T FH cells as well. Whether there is a generalized defect in T FH cells in IL-23R-deficient mice or just IL-17-producing cells remains to be clarified. Nevertheless, our observations suggest involvement of ICOS in regulating IL-23R expression and IL-17 production by T H -17 cells and T FH cells. Therefore, the lower T FH and T H -17 cell responses in ICOS-deficient mice might be due to a defect in c-Maf upregulation and IL-21 production and, consequently, a defect in the upregulation of IL-23R on T H -17 and T FH cells. Although IL-21 and IL-23 are not crucial for initial T H -17 differentiation, they are crucial for the population expansion and maintenance of differentiated T H -17 cells. As our data have shown that ICOS regulates IL-23R on differentiating T H -17 cells, lack of IL-23R upregulation in ICOS-deficient cells might be one reason why ICOS-deficient mice have a defect in memory T H -17 responses. ICOS has been shown not only to costimulate T cell activation but also to induce T cell survival in other T cell subsets 45, 46 . It is likely that ICOS serves a similar function in the survival of T FH cells as well by regulating IL-21 production and IL-23R expression in IL-17-secreting T FH cells. Our data collectively suggest that ICOS regulates the fate of differentiated IL-17-producing T cells through the induction of c-Maf, which in turn induces IL-21.
METHODS
Animals and induction of EAE. Icos -/-mice were backcrossed onto the C57BL/ 6 background for ten generations. Icos -/-mice were genotyped by PCR as described 49 . Chimeric c-Maf-deficient mice were generated in the laboratory of I.-C.H. by reconstitution of recombination-activating gene-deficient BALB/c mice with fetal liver cells from c-Maf-deficient mice. All mice used for
